Webinar: Adaptive Sample Size Reassessment – Conditional Powers or Bayesian Predictive Power?
Cytel’s Executive Research Principal, Rajat Mukherjee discusses using a Bayesian Predictive Power (PP) calculation for Adaptive Sample Size [...]
ISPOR Signal Series: The New Science of Cause and Effect
The next ISPOR Signal series event will feature Judea Pearl, professor of computer science and director of the Cognitive Systems [...]
Cytel Consultant Discusses Using Rolling-Enrollment to Speed Up Clinical Trials, Reduce Costs, and Improve Patient Safety
In the traditional clinical trial model, patients are enrolled in a clinical trial and then the effects of a treatment [...]
On-Demand Cytel Webinar Highlights Basket Trials Using Oncology RWD
An on-demand webinar offered by Cytel details how information borrowing in basket trial studies can offer valuable insight. Basket trials [...]
Cytel Blog on Applying Bayesian Methods to COVID-19 Clinical Trials
A Cytel blog post discusses how Bayesian methods have impacted COVID-19 vaccine clinical trials. Using Bayesian statistics can improve study [...]
Cytel Research Specialist Discusses Benefits of Bayesian Network Models for Clinicians and Clinical Trials
A recent Cytel paper, published in JCO Clinical Cancer Informatics, uses a Bayesian Network Model to accurately predict outcomes in cancer [...]
Cytel Blog on Using Bayesian Methods to Improve Clinical Trials
A Cytel blog post discusses how using Bayesian methods can lead to several key benefits in clinical trial design, including [...]
Webinar on RWE in Medical Device Trials Featuring FDA Statistician
Cytel’s new webinar is now available, featuring insight from former FDA statistician Dr. Ram Tiwari, now Head of Statistical Methodology [...]
Using Bayesian Methods in Control Arms of Clinical Trials
The use of single arm trials has become more widespread, especially as the COVID-19 has forced clinical trials to change [...]
Creating Master Protocols for Clinical Trials with Bayesian Methods
Clinical researchers have sought to streamline protocols and to thereby improve both reproducibility and efficiency. As a result, the use [...]
Bayesian Models are Underused yet Powerful Tools
In a recent study, Cytel researchers discussed the benefits of Bayesian models. They’re a good choice for both single arm [...]
Bayesian Methods for Multiple Cohort Expansion (MuCE) designs
Cohort expansion trials where multiple dose(s) and multiple indication(s) need to be tested in parallel can present complex problems for [...]
Bart Heeg on New Trends in HEOR
In this two-part blog series, Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel company) discusses trends [...]
[Webinar] Bayesian Statistics and FDA Regulatory Acceptability
Bayesian statistics have been used in regulatory submissions to the Food and Drug Administration (FDA) for over 15 years in [...]
[Webinar] The Informative Bayesian: Meta-analytic Predictive (MAP) Priors
Real world data typically has a lot of missing information. This often requires imputation of missing values which is not [...]
Clinical Trial Design from a Program Perspective
Join Cytel’s co-founder, Nitin Patel, as he discusses the value in designing clinical trials from a program-level perspective. This webinar [...]
How Can Bayesian Borrowing Enhance Use of Real World Data (RWD)?
As the use of real-world data becomes more common in trial design and regulatory submission, Bayesian borrowing techniques are of [...]
